22 pending office actions • 16 art units • 22 examiners • 0 of 22 (0%) have an AI response strategy ready • 12 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 22 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 22 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 19 (86%) |
| §112 only | 1 (5%) |
| No statute on record | 2 (9%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GEIGER, RACHAEL L | 1 | 85.7% | +13.6% |
| SWARTWOUT, BRIANNA KENDALL | 1 | 46.0% | +62.0% |
| PAULUS, ERIN VIRGINIA | 1 | 37.5% | +83.3% |
| JOHNSON, KARA D | 1 | 69.1% | +24.2% |
| MARTIN, PAUL C | 1 | 42.0% | +21.7% |
| ROWLAND, STEVE | 1 | 77.6% | +17.8% |
| ANDERSON, JAMES D | 1 | 55.1% | +19.2% |
| MCCLELLAN, JAMES S | 1 | 79.1% | +12.9% |
| HULL, JAMES B | 1 | 44.8% | +52.7% |
| LI, BAO Q | 1 | 75.9% | +26.2% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18703100 | SUBCUTANEOUS ABRASION TREATMENT FOR STRETCH MARKS | GEIGER, RACHAEL L | 54d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18341584 | COMPOSITIONS AND METHODS FOR TREATING DISEASES ASSOCIATED WITH AN IMPRINTING DEFECT | ANDERSON, JAMES D | 171d overdue |
| 18424292 | COMPOUNDS AND METHODS FOR TREATMENT OF DIAMOND BLACKFAN ANEMIA | PAULUS, ERIN VIRGINIA | 45d overdue |
| 18320927 | SURGICAL REPAIR SIMULATION DEVICES | HULL, JAMES B | 28d overdue |
| 18607961 | METHODS AND COMPOSITIONS RELATING TO HIGH-THROUGHPUT MODELS FOR ANTIBODY DISCOVERY AND/OR OPTIMIZATION | SWARTWOUT, BRIANNA KENDALL | 11d overdue |
| 18320921 | SURGICAL REPAIR SIMULATION DEVICES | MCCLELLAN, JAMES S | 21d |
| 18352808 | SURGICAL REPAIR SIMULATION DEVICE | ROWLAND, STEVE | 27d |
| 18508057 | CARDIOMYOCYTES AND COMPOSITIONS AND METHODS FOR PRODUCING THE SAME | JOHNSON, KARA D | 30d |
| 18313158 | ADENO-ASSOCIATED VIRUS VECTORS | LI, BAO Q | 40d |
| Art Unit | Apps |
|---|---|
| 3715 | 3 |
| 1638 | 3 |
| 3771 | 2 |
| 1631 | 2 |
| 1644 | 1 |
| 1632 | 1 |
| 1653 | 1 |
| 1629 | 1 |
| 1671 | 1 |
| 1674 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18703100 | SUBCUTANEOUS ABRASION TREATMENT FOR STRETCH MARKS | GEIGER, RACHAEL L | 3771 | §103 | Non-Final OA | 54d | Pending | Apr 19, 2024 |
| 18607961 | METHODS AND COMPOSITIONS RELATING TO HIGH-THROUGHPUT MODELS FOR ANTIBODY DISCOVERY AND/OR OPTIMIZATION | SWARTWOUT, BRIANNA KENDALL | 1644 | §103 | Non-Final OA | 11d overdue | Pending | Mar 18, 2024 |
| 18424292 | COMPOUNDS AND METHODS FOR TREATMENT OF DIAMOND BLACKFAN ANEMIA | PAULUS, ERIN VIRGINIA | 1631 | §103 | Non-Final OA | 45d overdue | Pending | Jan 26, 2024 |
| 18508057 | CARDIOMYOCYTES AND COMPOSITIONS AND METHODS FOR PRODUCING THE SAME | JOHNSON, KARA D | 1632 | §103 | Non-Final OA | 30d | Pending | Nov 13, 2023 |
| 18286405 | CARDIOMYOCYTES AND COMPOSITIONS AND METHODS FOR PRODUCING THE SAME | MARTIN, PAUL C | 1653 | §103 | Non-Final OA | 61d | Pending | Oct 11, 2023 |
| 18352808 | SURGICAL REPAIR SIMULATION DEVICE | ROWLAND, STEVE | 3715 | §103 | Final Rejection | 27d | Pending | Jul 14, 2023 |
| 18341584 | COMPOSITIONS AND METHODS FOR TREATING DISEASES ASSOCIATED WITH AN IMPRINTING DEFECT | ANDERSON, JAMES D | 1629 | — | Non-Final OA | 171d overdue | Pending | Jun 26, 2023 |
| 18320921 | SURGICAL REPAIR SIMULATION DEVICES | MCCLELLAN, JAMES S | 3715 | §103 | Final Rejection | 21d | Pending | May 19, 2023 |
| 18320927 | SURGICAL REPAIR SIMULATION DEVICES | HULL, JAMES B | 3715 | §103 | Non-Final OA | 28d overdue | Pending | May 19, 2023 |
| 18313158 | ADENO-ASSOCIATED VIRUS VECTORS | LI, BAO Q | 1671 | §103 | Non-Final OA | 40d | Pending | May 05, 2023 |
| 18030733 | NOTCH4 ANTIBODIES AND USES THEREOF | HOWARD, ZACHARY C | 1674 | §112 | Non-Final OA | 114d overdue | Pending | Apr 06, 2023 |
| 18009645 | USE OF HEAT SHOCK PROTEIN INHIBITORS FOR THE TREATMENT OF NEURODEVELOPMENTAL DISORDERS | HUTTER, GILLIAN A | 1625 | §103 | Non-Final OA | 1d overdue | Pending | Dec 09, 2022 |
| 18009192 | COMPOSITIONS AND METHODS FOR RED BLOOD CELL DIFFERENTIATION | MCCORMICK, CATHERINE LYNN | 1638 | §103 | Non-Final OA | 17d overdue | Pending | Dec 08, 2022 |
| 17915911 | COMPUTER-BASED SYSTEMS AND DEVICES CONFIGURED FOR DEEP LEARNING FROM SENSOR DATA NON-INVASIVE SEIZURE FORECASTING AND METHODS THEREOF | MALAMUD, DEBORAH LESLIE | 3792 | §103 | Non-Final OA | 4d overdue | Pending | Sep 29, 2022 |
| 17794895 | ANAPLASTIC LYMPHOMA KINASE CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE | AMICK, THOMAS RUSSE | 1638 | §103 | Non-Final OA | 17d overdue | Pending | Jul 22, 2022 |
| 17738200 | Bioelectronic Devices to Support Transplanted Cells in Vivo for Encapsulated Cell Therapies | SHAH, NILAY J | 3783 | §103 | Final Rejection | 10d overdue | Pending | May 06, 2022 |
| 17767340 | METHODS AND COMPOSITIONS FOR TREATING ATAXIA TELANGIECTASIA | MCLEOD, AFRICA MHAIRIE | 1635 | Other | Final Rejection | 89d overdue | Pending | Apr 07, 2022 |
| 17764413 | BCL11A GUIDE AND BASE EDITOR DELIVERY | HUMPHRIES, NICHOLAS ADAM | 1631 | §103 | Non-Final OA | 89d overdue | Pending | Mar 28, 2022 |
| 17612465 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF DBA USING GATA1 GENE THERAPY | HILL, KEVIN KAI | 1638 | §103 | Final Rejection | 70d | Pending | Nov 18, 2021 |
| 17425272 | COMPOSITIONS AND METHODS FOR TREATING MUSCULAR DYSTROPHY AND RELATED DISORDERS | WHITEMAN, BRIAN A | 1636 | §103 | Non-Final OA | 29d | Pending | Jul 22, 2021 |
| 17058046 | METHODS FOR TREATING SPINAL CORD INJURY | CHONG, YONG SOO | 1623 | §103 | Final Rejection | 22d | Pending | Nov 23, 2020 |
| 16560358 | METHODS AND COLLAGEN PRODUCTS FOR TISSUE REPAIR | KNAUSS, CHRISTIAN D | 3771 | §103 | Non-Final OA | 5d | Pending | Sep 04, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial